Prevention of venous thromboembolism in medical patients - The need for documentation;Tromboseprofylakse til medisinske pasienter - Dokumentasjon savnes

Tidsskrift for den Norske Laegeforening

Volumn 118, Issue 16, 1998, Pages 2498-2501

  Johansen, Anne Mette ^a   Abildgaard, Ulrich ^a  

^a Hematologisk Avdeling   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; DOCUMENTATION; FIBRINOLYTIC THERAPY; HOSPITAL DEPARTMENT; HUMAN; INTERNAL MEDICINE; MEDICAL RECORD; NORWAY; PRACTICE GUIDELINE; QUESTIONNAIRE; THROMBOEMBOLISM; THROMBOPHLEBITIS; THROMBOSIS;

DOCUMENTATION; GUIDELINES; HOSPITAL DEPARTMENTS; HUMANS; INTERNAL MEDICINE; MEDICAL RECORDS; NORWAY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; THROMBOEMBOLISM; THROMBOLYTIC THERAPY; THROMBOPHLEBITIS; THROMBOSIS;

EID: 0032550897     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Andreassen G, Dahl OE. Klinisk diagnostikk av dyp venetrombose etter hofteprotesekirurgi. Tidsskr Nor Lægeforen 1997; 117: 2026-7.
2. Clagett GP, Anderson FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest 1995; 108 (suppl): 312-28.
3. Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U. A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deepvein thrombosis in acute ischemic stroke. Semin Thromb and Hemost 1990; 16 (suppl): 25-33.
4. Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CRM. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 26: 115-7.
5. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10: 448-50.
6. Kierkegaard A, Norgren L, Olsson CG, Carstenfors J, Persson G, Persson S. Incidence of deep vein thrombosis in bedridden non-surgical patients. Acta Med Scand 1987; 222: 409-14.
7. Dahan R, Houlbert D, Caulin C, Cuzin E, Viltart C, Woler M et al. Prevention of deep vein thrombosis in elderly medical in-patients by low molecular weight heparin: a randomized double-blind trial. Haemostasis 1986; 16: 159-64.
8. Levine MN. Cancer patients. I: Goldhaber SZ, red. Prevention of venous thromboembolism. New York: Marcel Dekker, 1993: 463-83.
9. Thromboembolic Risk Factors (THRIFT) Consensus Group. Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 1992; 305: 567-74.
10. Anderson FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med 1992; 152: 1660-4.
11. Diebold J, Lohrs U. Venous thrombosis and pulmonary embolism: a study of 5039 autopsies. Pathol Res Pract 1991: 187: 260-6.
12. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WP, McNamara PM et al. Risk factors for pulmonary embolism: the Framingham study. Am J Med 1983; 74: 1023-8.
13. Gross JS, Neufeld RR, Libow LS, Gerber I, Rodstein M. Autopsy study of the elderly institutionalized patient: review of 234 autopsies. Arch Intern Med 1988; 148: 173-6.
14. Rubinstein I, Murray D, Hoffstein V. Fatal pulmonary emboli in hospitalized patients: an autopsy study. Arch Intern Med 1988; 148: 1425-6.
15. Taubman LB, Silverstone FA. Autopsy proven pulmonary embolism among the institutionalized elderly. J Am Geriatr Soc 1986; 34: 752-6.
16. Karwinski B, Svendsen E. Comparison of clinical and postmortem diagnosis of pulmonary embolism. J Clin Pathol 1989; 42: 135-9.
17. Halkin H, Goldberg J, Modan M, Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982; 96: 561-5.
18. Lechler E, Schramm W, Flosbach CW, the Prime study group. The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (Enoxaparin). Haemostasis 1996; 26 (suppl 2): 49-56.
19. Harenberg J, Roebruck P, Heene DL. Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. Haemostasis 1996; 26: 127-39.
20. Terapianbefalinger. Profylakse og behandling av dyp venetrombose og lungeembolisme. Nytt fra Statens legemiddelkontroll 1994; 17 nr. 11: 4, 30.